Atlas Trials

Combination Chemotherapy With or Without Bortezomib in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma

Clinical trial NCT00513955 · COMPLETED

Trial details

NCT number
NCT00513955
Sponsor
University Hospital Plymouth NHS Trust
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Lymphoma
Start date
2006-06-01
Primary completion
2014-10-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.